Status:
NOT_YET_RECRUITING
Standard Oxytocin Versus High Dose Oxytocin to Control Postpartum Hemorrhage in High Risk Pregnancy During Elective Cesarean Section
Lead Sponsor:
Ain Shams University
Conditions:
Post Partum Hemorrhage
Eligibility:
FEMALE
20-45 years
Phase:
NA
Brief Summary
Controlling hemorrhage during and after a cesarean section reduces significantly maternal mortality and morbidity and the present study is important for detection of the effectiveness of routinely inc...
Eligibility Criteria
Inclusion
- \- Medical disorders ie: Hypertensive diseases with pregnancy - Diabetes Mellitus - Collagen diseases - Coagulopathies - Cardiac diseases - Anemia
- History of postpartum hemorrhage
- Placental disorders ie: placenta previa
- Infertility and ICSI
- High Parity
- History of Endometriosis
- Fetal disorders (IUGR, IUFD, Preterm, Congenital anomalies, oligohydramnios or polyhydramnios, macrosomia)
- Preterm labor on uterine relaxants
- Twins pregnancy
- Patients on antiplatelets and anticoagulants
- Uneventful antenatal care
Exclusion
- \- Oxytocin Allergy
- Normal uncomplicated pregnancy
- Emergency cesarean section
- Exhausted uterus due to trial of normal labor
- Couvelaire uterus
Key Trial Info
Start Date :
August 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 25 2025
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06560099
Start Date
August 25 2024
End Date
April 25 2025
Last Update
August 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.